Cooke R P, Riordan T, Jones D M, Painter M J
Public Health Laboratory, Withington Hospital, Manchester.
BMJ. 1989 Mar 4;298(6673):555-8. doi: 10.1136/bmj.298.6673.555.
To determine the incidence of secondary meningococcal infection in close family and household contacts of index patients and to review the efficacy of chemoprophylaxis the records of 3256 cases occurring from 1984 through 1987 were examined. Seventeen secondary cases (0.5%) of infection were identified among these groups. The median interval between index and secondary cases was seven weeks. Fourteen secondary cases occurred more than one week after the disease was diagnosed in the index case. Three secondary cases had not received chemoprophylaxis and in another case the infecting strain had acquired resistance to rifampicin. Prophylaxis for the close contacts of 10 out of 11 of the remaining index patients failed to fulfil all the criteria of an optimal regimen. Even after optimal chemoprophylaxis the medical practitioner and the family should be aware of the increased and prolonged risk of secondary meningococcal infection among close contacts of patients with the disease.
为确定首例患者的密切家庭成员和同住者中继发性脑膜炎球菌感染的发生率,并评估化学预防的效果,我们检查了1984年至1987年期间发生的3256例病例的记录。在这些人群中发现了17例(0.5%)继发性感染病例。首例病例与继发性病例之间的中位间隔时间为7周。14例继发性病例在首例病例疾病诊断后1周以上出现。3例继发性病例未接受化学预防,另有1例感染菌株对利福平产生了耐药性。其余11例首例患者中,有10例的密切接触者的预防措施未完全符合最佳方案的所有标准。即使采取了最佳的化学预防措施,医生和患者家属也应意识到,该病患者的密切接触者发生继发性脑膜炎球菌感染的风险增加且持续时间延长。